1. Home
  2. KODK vs SLS Comparison

KODK vs SLS Comparison

Compare KODK & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastman Kodak Company

KODK

Eastman Kodak Company

HOLD

Current Price

$9.97

Market Cap

982.9M

ML Signal

HOLD

Logo SELLAS Life Sciences Group Inc.

SLS

SELLAS Life Sciences Group Inc.

HOLD

Current Price

$12.31

Market Cap

924.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KODK
SLS
Founded
1880
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
982.9M
924.5M
IPO Year
1994
2007

Fundamental Metrics

Financial Performance
Metric
KODK
SLS
Price
$9.97
$12.31
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
733.6K
6.2M
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.00
EPS
N/A
N/A
Revenue
$4,114,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$110.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.73
$1.39
52 Week High
$14.87
$15.88

Technical Indicators

Market Signals
Indicator
KODK
SLS
Relative Strength Index (RSI) 66.48 56.10
Support Level $9.13 $12.00
Resistance Level $10.17 $15.88
Average True Range (ATR) 0.44 0.95
MACD 0.22 0.02
Stochastic Oscillator 85.50 93.67

Price Performance

Historical Comparison
KODK
SLS

About KODK Eastman Kodak Company

Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: